Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Apr 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5035020010 | Gilteritinib fumarate (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5035021014 | Gilteritinib fumarate | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Gilteritinib fumarate (substance) | Is a | Antineoplastic agent (substance) | true | Inferred relationship | Some | ||
| Gilteritinib fumarate (substance) | Is a | Protein-tyrosine kinase inhibitor | true | Inferred relationship | Some | ||
| Gilteritinib fumarate (substance) | Is a | Enzyme inhibitor | false | Inferred relationship | Some | ||
| Gilteritinib fumarate (substance) | Is a | Pyrazine (substance) | true | Inferred relationship | Some | ||
| Gilteritinib fumarate (substance) | Has disposition (attribute) | Protein-tyrosine kinase inhibitor (disposition) | true | Inferred relationship | Some | ||
| Gilteritinib fumarate (substance) | Is modification of (attribute) | Gilteritinib (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Gilteritinib (as gilteritinib fumarate) 40 mg oral tablet | Has precise active ingredient | True | Gilteritinib fumarate (substance) | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR